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Background
In vivo multi-modality cellular and molecular imaging of
the engrafted iCMs is necessary to characterize the
engraftment and the regional effects on the viability of
the injured myocardium. Zinc finger nuclease (ZFN)-
mediated integration of the reporter gene into the
AAVS1 locus in the iCMs and manganese enhanced
MRI (MEMRI) should allow precise in vivo detection of
myocardial regeneration.
Methods
In order to have multi-modal in vivo imaging of the
stem cells, ZFN technology was employed to integrate a
triple fusion RG (firefly luciferase (BLI), red fluorescent
protein (RFP), and herpes simplex virus thymidine
kinase (PET)) into the AAVS1 locus of iPSCs. iPSCs
monoclonal lines were then differentiated into iCMs,
under chemically defined conditions using CHIR (4 µM)
and C59 (2 µM) small molecules to modulate the Wnt
pathway activity. The produced iCMs were then fully
characterized and injected into mice and tracked with
several techniques.
Results
Co-localization of cardiac phenotype and striated mor-
phology, flow cytometry measurement of 93% cardiac
troponin (cTNT) associated with 75% VCAM and 49%
CIRPA cell surface markers, the atomic force measure-
ment with calcium flux were observed, which confirmed
normal function of the iCMs (Fig. 1A). The iCMs were,
then, transplanted into murine myocardial injury model.
Two and four weeks post-injury, left ventricular ejection
fraction (LVEF) was better preserved in the iCM-treated
vs. PBS-treated mice (week 2: 33.1±4.4% vs. 26.1±7.9%,
p<0.05 and at week 4: 35.1±8.4% vs. 16.1±0.2%, p<0.05).
MEMRI also demonstrated increased % myocardial via-
bility by iCMs at week 2 measured 67.3±13.1%, which
decreased slightly by -2.3±0.3% at week 4 while PBS
treated cases conferred significant decrease -17.4% at
week 4 (p<0.05). Finally, the mean BLI signal, indicating
iCM engraftment, demonstrated on days 14 (n=3) is 2.1
±0.6 x103p/s/cm2/sr and days 28 (n=3) is 4.2±2.2 x103p/
s/cm2/sr. Robust in vivo expression of ZFN-edited BLI
signal of iCM engraftment and sustained MEMRI signal
of myocardial viability over 4-week duration demon-
strated regeneration of the injured myocardium (Figs.
1B and 1C).
Conclusions
This study demonstrates the successful use of in vivo
multi-modality imaging to confirm the regeneration of
the injured myocardium. ZFN technology enables tar-
geted site-specific insertion of RGs and MEMRI allows
direct evaluation of myocardial viability. These imaging
capabilities will allow clinical translation of iCMs.
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Figure 1 A): a) Optical microscopy of the human pluripotent cell-derived cardiomyocytes (iCMs); b) Confocal image of the iCMs immunolabeled
for alpha-Actinitn (green), cardiac TroponinT (red), Connexin43 (violet) and nuclei (blue); c) flow cytometry results showing the existence of cTnT
and VCAM1 positive iCMs; d) spontaneous atomic force microscopy (AFM) measurement and calcuim flux in iCMs B) Bioluminescence of RG
Luciferase activity from human cells in heart at week 4 after transplant. B) BLI signal of the mice after 2 weeks (top panel) and 4 weeks (bottom
panel) of iCM injection. C) MEMRI images of iCMs injection (after 2 (top panel) and 4 weeks (bottom panel)) for myocardial infarct.
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